{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:19:03Z","timestamp":1790345943664,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,2]],"date-time":"2027-09-02T00:00:00Z","timestamp":1819843200000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA278051"],"award-info":[{"award-number":["R01 CA278051"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001395","name":"Wisconsin Alumni Research Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015982","name":"Midwest Athletes Against Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"Saint Baldricks Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020317","name":"Grainger Institute for Engineering, University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.05.029","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:21:58Z","timestamp":1780503718000},"page":"5190-5206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Directing fratricide within T cell products using an anti-uPAR chimeric antigen receptor to drive the production of potent therapeutic cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Lauren E.","family":"Sarko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Givand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Rattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Shepley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshini M.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Upadhyaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Mnuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cavin","family":"Gehrke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Murren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler K.","family":"Ulland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Capitini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Kotanchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-0858","authenticated-orcid":false,"given":"Krishanu","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.05.029_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1388475","article-title":"Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review","volume":"14","author":"Moradi","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.029_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202100071","article-title":"Cas9-cleavage sequences in size-reduced plasmids enhance nonviral genome targeting of CARs in primary human T cells","volume":"5","author":"Jing","year":"2021","journal-title":"Small Methods"},{"key":"10.1016\/j.ymthe.2026.05.029_bib4","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211530","article-title":"High-efficiency nonviral CRISPR\/Cas9-mediated gene editing of human T cells using plasmid donor DNA","volume":"219","author":"Oh","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.05.029_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101437","article-title":"Efficient nonviral integration of large transgenes into human T cells using Cas9-CLIPT","volume":"33","author":"Tommasi","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.05.029_bib6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fbioe.2020.00678","article-title":"Straightforward generation of ultrapure off-the-shelf allogeneic CAR-T cells","volume":"8","author":"Juillerat","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib7","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41587-024-02531-6","article-title":"SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci","volume":"43","author":"Chang","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.omtm.2018.04.002","article-title":"Efficient enrichment of gene-modified primary T cells via CCR5-targeted integration of mutant dihydrofolate reductase","volume":"9","author":"Paul","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.05.029_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/mt.2015.104","article-title":"A multidrug-resistant engineered CAR T cell for allogeneic combination immunotherapy","volume":"23","author":"Valton","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065519","article-title":"Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy","volume":"8","author":"Jonnalagadda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.05.029_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/CM9.0000000000003046","article-title":"Targeting metabolism to improve CAR-T cells therapeutic efficacy","volume":"137","author":"Liu","year":"2024","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ymthe.2026.05.029_bib12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.05.029_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.omto.2022.05.012","article-title":"Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo","volume":"26","author":"Bister","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2026.05.029_bib14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood-2014-01-545020","article-title":"A highly compact epitope-based marker\/suicide gene for easier and safer T-cell therapy","volume":"124","author":"Philip","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.05.029_bib15","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/j.ymthe.2023.09.021","article-title":"Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development","volume":"31","author":"Tang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/cancers13020197","article-title":"Bcl-2 enhances chimeric antigen receptor T cell persistence by reducing activation-induced apoptosis","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2026.05.029_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70283","article-title":"Unlocking apoptotic pathways: Overcoming tumor resistance in CAR-T-cell therapy","volume":"13","author":"Zhang","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.ymthe.2026.05.029_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12943-024-02079-8","article-title":"Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy","volume":"23","author":"Xia","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.05.029_bib19","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1038\/s41467-025-59713-2","article-title":"Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy","volume":"16","author":"Borot","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.029_bib20","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1038\/s41467-024-52666-y","article-title":"GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency","volume":"15","author":"Guerrero","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.05.029_bib21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.immuni.2016.02.023","article-title":"Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.05.029_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006522","article-title":"Metabolic reprogramming via an engineered PGC-1\u03b1 improves human chimeric antigen receptor T-cell therapy against solid tumors","volume":"11","author":"Lontos","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.05.029_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T cell therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.05.029_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.copbio.2018.01.025","article-title":"A guide to manufacturing CAR T cell therapies","volume":"53","author":"Vormittag","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41586-022-05626-9","article-title":"Functional T cells are capable of supernumerary cell division and longevity","volume":"614","author":"Soerens","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.029_bib26","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/trf.18354","article-title":"Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells","volume":"65","author":"Vu\u010dini\u0107","year":"2025","journal-title":"Transfusion"},{"key":"10.1016\/j.ymthe.2026.05.029_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s43587-023-00560-5","article-title":"Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction","volume":"4","author":"Amor","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.ymthe.2026.05.029_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.029_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1951","article-title":"NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates","volume":"15","author":"Yang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.05.029_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41420-024-01976-7","article-title":"Targeting senescent cells with NKG2D-CAR T cells","volume":"10","author":"Deng","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ymthe.2026.05.029_bib31","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.cell.2026.03.002","article-title":"A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy","volume":"189","author":"Zhang","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.05.029_bib32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.18609\/cgti.2023.132","article-title":"Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer\u2019s disease","volume":"9","author":"Sarko","year":"2023","journal-title":"CGTI"},{"key":"10.1016\/j.ymthe.2026.05.029_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109173","article-title":"Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells","volume":"117","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2026.05.029_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084111","article-title":"The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications","volume":"22","author":"Santi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.05.029_bib35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat. Rev. Mol. Cel Biol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1146\/annurev.immunol.20.100301.064807","article-title":"Protein kinase C(theta) in T cell activation","volume":"20","author":"Isakov","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.152.2.505","article-title":"Urokinase receptor. An activation antigen in human T lymphocytes","volume":"152","author":"Nykjaer","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004446","article-title":"Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression","volume":"10","author":"Mueller","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.05.029_bib39","article-title":"Metabolic priming of GD2 TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence","author":"Cappabianca","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.05.029_bib40","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ymthe.2025.01.024","article-title":"Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells","volume":"33","author":"Shankar","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.05.029_bib42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41587-020-0555-7","article-title":"CHANGE-seq reveals genetic and epigenetic effects on CRISPR\u2013Cas9 genome-wide activity","volume":"38","author":"Lazzarotto","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf1333","article-title":"A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells","volume":"7","author":"Bozza","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.05.029_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41551-023-01073-7","article-title":"Enhancement of the viability of T cells electroporated with DNA via osmotic dampening of the DNA-sensing cGAS-STING pathway","volume":"8","author":"An","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.05.029_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ymthe.2022.09.003","article-title":"Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies","volume":"31","author":"Watanabe","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1786","article-title":"Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling","volume":"372","author":"Weber","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.05.029_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5907","article-title":"The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on\/off switch for CAR T cells","volume":"11","author":"Mestermann","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.05.029_bib48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.ATV.18.5.693","article-title":"Binding of human Urokinase-type plasminogen activator to its receptor","volume":"18","author":"Quax","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0021-9258(19)85069-X","article-title":"Characterization of the cellular binding site for the urokinase-type plasminogen activator","volume":"264","author":"Estreicher","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.05.029_bib50","series-title":"Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products","year":"2024"},{"key":"10.1016\/j.ymthe.2026.05.029_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-022-03442-3","article-title":"Exhaustion of CAR T cells: potential causes and solutions","volume":"20","author":"Kouro","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.05.029_bib52","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1073\/pnas.1712107115","article-title":"Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion","volume":"115","author":"Avery","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.05.029_bib53","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4049\/jimmunol.1400557","article-title":"Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion","volume":"193","author":"Ferris","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib54","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.ymthe.2019.06.001","article-title":"Fresh versus frozen: Effects of cryopreservation on CAR T cells","volume":"27","author":"Hanley","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib55","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ymthe.2019.05.015","article-title":"Effect of cryopreservation on autologous chimeric antigen receptor T cell characteristics","volume":"27","author":"Panch","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1249929","article-title":"Biology of GD2 ganglioside: implications for cancer immunotherapy","volume":"14","author":"Machy","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib57","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fonc.2020.01000","article-title":"Disialoganglioside GD2 expression in solid tumors and role as a target for cancer therapy","volume":"10","author":"Nazha","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib58","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1182\/blood-2002-06-1842","article-title":"Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration","volume":"101","author":"Pluskota","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.05.029_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1546172","article-title":"Tandem CAR-T cell therapy: recent advances and current challenges","volume":"16","author":"G\u00f3mez-Melero","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1049","article-title":"Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations","volume":"8","author":"Weinkove","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.915837","article-title":"Gamma delta T-cell based cancer immunotherapy: Past-present-future","volume":"13","author":"Saura-Esteller","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib62","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1561174","article-title":"New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies","volume":"16","author":"Rassek","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108587","article-title":"Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages","volume":"106","author":"Ebrahimiyan","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib65","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-020-01741-4","article-title":"Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies","volume":"11","author":"Shankar","year":"2020","journal-title":"Stem Cel Res. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib66","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/mt.2013.59","article-title":"HLA engineering of human pluripotent stem cells","volume":"21","author":"Riolobos","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.05.029_bib67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(00)80681-0","article-title":"Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression","volume":"4","author":"Chang","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.05.029_bib68","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.stem.2024.02.001","article-title":"Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate","volume":"31","author":"Hu","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.05.029_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ymthe.2026.05.029_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878209","article-title":"CAR-T cell performance: How to improve their persistence?","volume":"13","author":"L\u00f3pez-Cantillo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.05.029_bib71","article-title":"Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives","volume":"12","author":"Shahzadi","year":"2024","journal-title":"Ther. Adv. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2026.05.029_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2025.03.249","article-title":"Accelerating CAR-T manufacturing: Establishing an AI and automation-driven analytical development platform","volume":"27","author":"Lebrun","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2026.05.029_bib73","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1126\/science.abq0225","article-title":"Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning","volume":"378","author":"Daniels","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.05.029_bib74","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41551-024-01219-1","article-title":"A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells","volume":"8","author":"Sin","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.05.029_bib75","unstructured":"PLAUR (NM_001005377) Human Tagged ORF Clone https:\/\/www.origene.com\/catalog\/cdna-clones\/expression-plasmids\/rc215350-plaur-nm-001005377-human-tagged-orf-clone."},{"key":"10.1016\/j.ymthe.2026.05.029_bib76","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","article-title":"Cellpose: a generalist algorithm for cellular segmentation","volume":"18","author":"Stringer","year":"2021","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626004739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626004739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:23:04Z","timestamp":1788362584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626004739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525001626004739"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.05.029","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Directing fratricide within T cell products using an anti-uPAR chimeric antigen receptor to drive the production of potent therapeutic cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}